March 26, 2022 Comments Off on New patent for Zogenix Inc drug FINTEPLA Posted in: Patent Added Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…
March 24, 2022 Comments Off on New patent for Pfizer drug XELJANZ XR Posted in: Patent Added Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent for Pfizer drug XELJANZ XR appeared first on DrugPatentWat…